Phage neutralization by sera of patients receiving phage therapy

Viral Immunology

Volumn 27, Issue 6, 2014, Pages 295-304

  Łusiak Szelachowska, Marzanna ^a   Zaczek, Maciej ^a   Weber Dabrowska, Beata ^a   Miȩdzybrodzki, Ryszard ^a,b   Kłak, Marlena ^a   Fortuna, Wojciech ^a   Letkiewicz, Sławomir ^a   Rogóz, Paweł ^a   Szufnarowski, Krzysztof ^a,c   Jończyk Matysiak, Ewa ^a   Owczarek, Barbara ^a   Górski, Andrzej ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c REGIONAL SPECIALIST HOSPITAL   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIOPHAGE ANTIBODY; BACTERIUM ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ANTIPHAGE ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIOPHAGE TYPING; BONE INFECTION; BRONCHITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; LARYNGITIS; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MORGANELLA MORGANII; NONHUMAN; OTITIS; PHAGE THERAPY; PHARYNGITIS; PROSTATITIS; PSEUDOMONAS AERUGINOSA; RHINITIS; SERODIAGNOSIS; SERRATIA MARCESCENS; SERUM; SINUSITIS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VIRUS NEUTRALIZATION; BACTERIAL INFECTIONS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; VIRUS INACTIVATION;

ANTIBODIES, VIRAL; BACTERIAL INFECTIONS; BACTERIOPHAGES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUTRALIZATION TESTS; VIRUS INACTIVATION;

EID: 84903740818     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0128     Document Type: Article

References (14)

1. Adams MH. Antigenic properties. In: Bacteriophages. New York: Interscience, 1959a:96-119.
2. Adams MH. Methods of study of bacterial viruses. In: Bacteriophages. New York: Interscience, 1959b:443-522.
3. Bruttin A, and Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 2005;49:2874-2878. (Pubitemid 40917605)
4. Górski A, Borysowski J, Mie{ogonek}dzybrodzki R, and Weber-Da{ogonek}browska B. Bacteriophages in medicine. In: McGrath S and van Sinderen D, eds. Bacteriophage. Genetics and Molecular Biology. Norfolk, United Kingdom: Caister Academic Press, 2007:125-157.
5. Górski A, Mie{ogonek}dzybrodzki R, Borysowski J, et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res 2012;83:41-71.
6. Gratia A. Des relations numeriques entre bacteries lysogenes et particles de bacteriophage. Ann Inst Pasteur 1936;57:652-676.
7. Hedström SA, and Kamme C. Antibodies against staphylococcal bacteriophages in human sera. II. Assay of anti-bodies in exacerbation and regression of chronic staphylococcal osteomyelitis. Acta Pathol Microbiol Scand B Microbiol Immunol 1973;81:749-752.
8. Kamme C. Antibodies against staphylococcal bacteriophages in human sera. I. Assay of antibodies in healthy individuals and in patients with staphylococcal infections. Acta Pathol Microbiol Scand B Microbiol Immunol 1973;81:741-748.
9. Kucharewicz-Krukowska A, and Ślopek S. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch Immunol Ther Exp 1987;35:553-561.
10. Mie{ogonek}dzybrodzki R, Borysowski J, Weber-Da{ogonek}browska B, et al. Clinical aspects of phage therapy. Adv Virus Res 2012;83:73-121.
11. Pescovitz MD, Torgerson TR, Ochs HD, et al. Effect of rituximab on human in vivo antibody immune responses. J Allergy Clin Immunol 2011;128:1295-1302.
12. Stashak PW, Baker PJ, and Roberson BS. The serum antibody response to bacteriophage phiX174 in germ-free and conventionally reared mice. Immunology 1970;18:307-317.
13. Sulakvelidze A, and Barrow P. Phage therapy in animals and agribusiness. In: Kutter E and Sulakvelidze A, eds. Bacteriophages. Biology and Applications. Boca Raton, FL: CRC Press, 2005:335-380.
14. Waddell TE, Franklin K, Mazzocco A, and Johnson RP. Preparation and characterization of anti-phage serum. In: Clokie MRJ and Kropinski AM, eds. Bacteriophages: Methods and Protocols. Vol. 1. Isolation, Characterization, and Interactions. New York: Humana Press, 2009:287-292.